Milestone Pharmaceuticals (MIST) Return on Equity [ROE] (2018 - 2022)
Milestone Pharmaceuticals (MIST) reported Return on Equity [ROE] of -76.85% for Q3 2022, down 50.91 percentage points from -25.94% a year earlier and down 26.54 percentage points from the prior quarter.
Powered by 
Analysis
Milestone Pharmaceuticals (MIST) Return on Equity [ROE] (2018 - 2022) Analysis & Trends
For FY2021, Milestone Pharmaceuticals posted Return on Equity [ROE] of -33.52%, up 5.21 percentage points from FY2020.
- By year, Return on Equity [ROE] came in at -38.73% in FY2020 (+16.93 pp) and -55.66% in FY2019.
- The Q3 2022 figure ranks as the lowest quarterly Return on Equity [ROE] since Q4 2018.
- Year over year, Return on Equity [ROE] gained in five of the last seven quarters, with an average year-over-year change of +4.60 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2019 (a gain of 79.79 percentage points); the low point was Q3 2022 (a drop of 50.91 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.97% |
| 10 | Milestone Pharmaceuticals | 96.39 Mn | -74.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -76.85% |
| Jun 30, 2022 | -50.31% |
| Dec 31, 2021 | -35.71% |
| Sep 30, 2021 | -25.94% |
| Jun 30, 2021 | -23.85% |
| Mar 31, 2021 | -33.54% |
| Dec 31, 2020 | -40.74% |
| Sep 30, 2020 | -62.65% |
| Jun 30, 2020 | -64.42% |
| Mar 31, 2020 | -56.98% |
| Dec 31, 2019 | -44.58% |
| Sep 30, 2019 | -33.55% |
| Jun 30, 2019 | -36.16% |
| Mar 31, 2019 | -37.55% |
| Dec 31, 2018 | -124.38% |
API Access
Milestone Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MIST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MIST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MIST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();